RxDoctor Payments Data

Emily Bell, MD

Family Medicine · Indianapolis, INNPI 1952448995

Payments from drug & device makers

$381in general payments, 2019–2025

Across 24 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$104
  • GSK$94
  • Novo Nordisk$35
  • Vivus LLC$24
  • Boehringer Ingelheim$21
  • Astellas Pharma US Inc$20
  • plus $84 from 5 others

What the payments were for

  • Food & beverage$381100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$381 in reported general payments places this provider in the 40th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$40,356
Medicare patients
109
Services billed
710

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide83$114,255
MounjaroTirzepatide32$50,990
EliquisApixaban27$28,494
TrulicityDulaglutide21$22,492
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$17,754
MyrbetriqMirabegron15$17,134
ArexvyRsvpref3 Antigen/As01e/Pf45$13,649
Breo ElliptaFluticasone/Vilanterol14$11,661
Rosuvastatin Calcium226$3,358
Esomeprazole Magnesium18$3,066
Duloxetine Hcl60$2,772
Omeprazole140$2,691
ShingrixVaricella-Zoster Ge/As01b/Pf12$2,635
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$2,602
Atorvastatin Calcium249$2,465

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$35$114,25583 claims
Lilly USA, LLCMounjaro, Trulicity$13$73,48253 claims
GSKTrelegy Ellipta, Arexvy, Breo Ellipta, Shingrix$94$45,69992 claims
PfizerEliquis$104$28,49427 claims
Astellas Pharma US IncMyrbetriq$20$17,13415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →